Filing Details

Accession Number:
0001209191-22-047714
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-26 16:30:45
Reporting Period:
2022-08-19
Accepted Time:
2022-08-26 16:30:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841330 Pasithea Therapeutics Corp. KTTA () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1824520 Leonite Capital Llc 1 Hillcrest Center Dr., Suite 232
Spring Valley NY 10977
No No No Yes
1883076 Avi Geller C/O Leonite Capital Llc
1 Hillcrest Center Drive, Suite 232
Spring Valley NY 10977
No No No Yes
1944053 Leonite Fund I, Lp C/O Leonite Capital Llc
1 Hillcrest Center Drive, Suite 232
Spring Valley NY 10977
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-19 54,644 $1.30 54,644 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,034,702 Indirect See footnote
Footnotes
  1. The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP.
  2. The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.